| Line Item | 2025-08-29 | Y/Y |
|---|---|---|
| Revenue | $1.37B | +16.9% |
| Cost of Revenue | $974.5M | +17.4% |
| Gross Profit | $394.3M | +15.7% |
| R&D Expense | $79.8M | -2.1% |
| SG&A Expense | $238.2M | +1.8% |
| Operating Income | $58.1M | +217.8% |
| Pre-tax Income | $48.9M | +256.9% |
| Income Tax | $20.1M | +89.0% |
| Net Income | $25.4M |
| Line Item | 2025-08-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $453.8M | +18.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $307.9M | +22.3% |
| Inventory | $255.2M | +68.8% |
| Current Assets | $1.06B | +22.6% |
| Total Assets | $1.62B | +9.7% |
| Current Liabilities | $473.9M | +44.7% |
| Line Item | 2025-08-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $109.1M | +41.3% |
| Capital Expenditures | $9.0M | -53.6% |
| Investing Cash Flow | $25.0M | -76.8% |
| Financing Cash Flow | -$63.5M | +69.8% |
| Free Cash Flow | $100.1M | +73.3% |
| +148.4% |
| EPS (Basic) | $0.29 | +129.0% |
| EPS (Diluted) | $0.28 | +128.0% |
| Long-term Debt |
| $461.8M |
| -29.7% |
| Total Liabilities | $1.01B | -6.2% |
| Stockholders' Equity | $394.2M | +0.7% |